This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on January 24, 2023.
Return to the list of Patented Medicine Litigation page.
DEXILANT, DEXLANSOPRAZOLE, KAPIDEX – Takeda Canada Inc. (NOC Search)
- 2463690: APOTEX
- 2499574: APOTEX
- 2570916: APOTEX
- 2671369: APOTEX
- 2702356: APOTEX
- 2737851: APOTEX
- 2771725: APOTEX
- PM(NOC) – A-9-12 (2013 FCA 13) – T-2044-10 (2011 FC 1444)
- PM(NOC) – T-151-22 (2023 FC 63) – T-2034-22
Return to the Patented Medicine Litigation page.